Publication | Open Access

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematologyPathologyLate-onset NeutropeniaCd20-positive B-cell LymphomaHigh IncidenceAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyCancer ResearchHealth Sciences